Qhslab, INC. (USAQ) — SEC Filings

Overview

Qhslab, INC. (USAQ) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 21, 2026: QHSLab, Inc. filed an 8-K on April 21, 2026, primarily for Regulation FD Disclosure and to file Financial Statements and Exhibits. The filing includes an exhibit (EX-99.1) which contains a graphic, suggesting it may be related to a product launch, investor presentation, or other material information

Sentiment Summary

Across 41 filings, the sentiment breakdown is: 2 bearish, 38 neutral, 1 mixed. The dominant filing sentiment for Qhslab, INC. is neutral.

Filing Type Overview

Qhslab, INC. (USAQ) has filed 32 8-K, 3 10-K, 6 10-Q with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (41)

• QHSLab, Inc. Files 8-K with Exhibits — 8-K · Apr 21, 2026 Risk: medium
  QHSLab, Inc. filed an 8-K on April 21, 2026, primarily for Regulation FD Disclosure and to file Financial Statements and Exhibits. The filing includes an exhibi
• QHSLab Swings to Profit on Debt Relief, But 'Going Concern' Looms — 10-K · Mar 30, 2026 Risk: high
  QHSLab, Inc. (USAQ) reported a net income of $457,417 for the fiscal year ended December 31, 2025, a significant improvement from a net loss of $259,239 in 2024
• QHSLab, Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 29, 2025 Risk: medium
  On December 26, 2025, QHSLab, Inc. entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity securities and provid
• QHSLab, Inc. Files 8-K — 8-K · Dec 3, 2025 Risk: low
  QHSLab, Inc. filed an 8-K on December 3, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly
• QHSLab, Inc. Files 8-K with Office Location and Name History — 8-K · Dec 1, 2025 Risk: low
  On December 1, 2025, QHSLab, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 901 Northpoint Parkway, Sui
• 8-K Filing — 8-K · Nov 24, 2025
• 8-K Filing — 8-K · Nov 18, 2025
• USAQ Revenue Jumps 32%, But Soaring Costs Drive Net Loss — 10-Q · Nov 13, 2025 Risk: high
  QHSLab, Inc. (USAQ) reported a mixed financial performance for the nine months ended September 30, 2025. Revenue increased significantly to $1,987,931, up from
• QHSLab, Inc. Files 8-K Report — 8-K · Sep 2, 2025 Risk: low
  On September 2, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. T
• QHSLab Revenue Jumps 30%, But Losses Widen Amid Soaring Costs — 10-Q · Aug 14, 2025 Risk: high
  QHSLab, Inc. reported a significant increase in revenue for the three and six months ended June 30, 2025. Revenue for the three-month period rose to $605,446 fr
• QHSLab, Inc. Files 8-K for Disclosure and Exhibits — 8-K · Jul 8, 2025 Risk: low
  On July 8, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and the filing of Financial State
• QHSLab, Inc. Files 8-K Report — 8-K · Jun 3, 2025 Risk: low
  On June 3, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, fo
• QHSLab, Inc. Files 8-K: Regulation FD & Exhibits — 8-K · May 21, 2025 Risk: low
  QHSLab, Inc. filed an 8-K on May 21, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated
• QHSLab, Inc. Files 8-K: Regulation FD & Financials — 8-K · May 16, 2025 Risk: low
  On May 16, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. The co
• QHSLab, Inc. Files 8-K: Regulation FD & Financials — 8-K · May 15, 2025 Risk: low
  QHSLab, Inc. filed an 8-K on May 15, 2025, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQ
• QHSLab, Inc. Files Q1 2025 10-Q — 10-Q · May 14, 2025 Risk: low
  QHSLab, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance shee
• QHSLab, Inc. Files 2024 Annual Report — 10-K · Mar 28, 2025 Risk: low
  QHSLab, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting its financial performance and business operations. The company, formerly kno
• QHSLab, Inc. Files 8-K: Name Change History — 8-K · Feb 26, 2025 Risk: low
  On February 26, 2025, QHSLab, Inc. filed an 8-K report. The filing indicates a change in the company's name from USA EQUITIES CORP. to QHSLab, Inc. on November
• QHSLab, Inc. Reports Accelerated Financial Obligation — 8-K · Feb 25, 2025 Risk: medium
  On February 20, 2025, QHSLab, Inc. reported a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance
• QHSLab, Inc. Files 8-K Report — 8-K · Feb 18, 2025 Risk: low
  On February 18, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. The company,
• QHSLab, Inc. Files 8-K with Regulatory Disclosures — 8-K · Feb 11, 2025 Risk: low
  On February 11, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includes financial state
• QHSLab, Inc. Files 8-K Report — 8-K · Jan 21, 2025 Risk: low
  On January 21, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. Th
• QHSLab, Inc. Files 8-K Report — 8-K · Jan 16, 2025 Risk: low
  On January 16, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company
• QHSLab, Inc. Files 8-K for Reg FD and Financials — 8-K · Dec 16, 2024 Risk: low
  On December 16, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and Exhibi
• QHSLab, Inc. Files 8-K Report — 8-K · Dec 13, 2024 Risk: low
  On December 13, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily serves as a notification of information and includes financial statements and exhib
• QHSLab, Inc. Files 8-K: Regulation FD & Financials — 8-K · Nov 25, 2024 Risk: low
  On November 25, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The compan
• QHSLab, Inc. Files 8-K: Regulation FD & Financials — 8-K · Nov 14, 2024 Risk: low
  On November 13, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The compan
• QHSLab, Inc. Files Q3 2024 10-Q — 10-Q · Nov 13, 2024 Risk: low
  QHSLab, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is
• QHSLab, Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Oct 22, 2024 Risk: medium
  On October 18, 2024, QHSLab, Inc. entered into a material definitive agreement. The company also disclosed unregistered sales of equity securities and provided
• QHSLab, Inc. Files 8-K: Regulation FD Disclosure & Exhibits — 8-K · Oct 21, 2024 Risk: low
  On October 21, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includes Financial Statem
• QHSLab, Inc. Files 8-K for Disclosure and Exhibits — 8-K · Sep 25, 2024 Risk: low
  On September 25, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Ex
• QHSLab, Inc. Files 8-K Report — 8-K · Sep 17, 2024 Risk: low
  On September 17, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. The company,
• QHSLab, Inc. Files 10-Q for Q2 2024 — 10-Q · Aug 14, 2024 Risk: low
  QHSLab, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is inco
• QHSLab, Inc. Changes Independent Auditor — 8-K · Jun 7, 2024 Risk: medium
  QHSLab, Inc. announced on June 7, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting f
• QHSLab, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024 Risk: low
  QHSLab, Inc. (USAQ) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. QHSLab, Inc. filed a 10-Q report for the period ending March 31, 2024. The com
• QHSLab, Inc. Files 8-K Report — 8-K · May 2, 2024 Risk: low
  On May 2, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, for
• QHSLab, Inc. Files 8-K Report — 8-K · Apr 26, 2024 Risk: low
  On April 26, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company,
• 8-K Filing — 8-K · Apr 18, 2024
• QHSLab, Inc. Files 8-K Report — 8-K · Mar 28, 2024 Risk: low
  On March 28, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company,
• QHSLab, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 27, 2024 Risk: medium
  QHSLab, Inc. (USAQ) filed a Annual Report (10-K) with the SEC on March 27, 2024. QHSLab, Inc. (formerly USA Equities Corp.) filed its annual report for the fisc
• QHSLab Files 8-K: Confirms Corporate Details & Exchange Act Status — 8-K · Jan 30, 2024
  QHSLab, Inc. filed an 8-K on January 30, 2024, primarily to disclose general corporate information and confirm its current status as a public company. The filin

Frequently Asked Questions